Isolated limb Perfusion (ILP) is a treatment in which the blood circulation is isolated in an extremity providing local treatment with chemotherapy using a heart lung maching. The purpose is to give large doses of tumor toxic medications which are 15 to 20 fold higher than can be given by systemic treatment. The treatment provides an increased cytostatic effect on the tumor with minimal systemic exposure.
Healthcare professionals
Commercially oriented stakeholders
Results so far
Today, ILP is an established treatment method for regionally advanced malignant melanoma and for advanced soft tissue sarcoma limited to an extremity. In most cases, the treatment leads to complete remission of the tumor. In some cases, ILP leads to partial remission or stabilization of the illness.
What’s Going On
Different target groups
We expect a variety of audiences. For example, we received teams from all over the world who work in Cardiothoracic surgery. We also received commercially oriented stakeholders.
Training methods
Protocol and patient management, Wet lab, Hands-on and troubleshooting, Simulation training, Scientific presentations
ECMO/ ECLS Simulation training with a variety of patients scenario’s
- Continuous bleeding of an ECLS patiënt
- Clotting of the system
- Cannulae displacement
- Sepsis
- Lung oedema
- Kinking of tubing during transport
- Volume shifts in the patient
Quantum training
We are proud to say we are the first clinical users of the new Quantum heart lung machine.
